Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2026-03-03 @ 2:32 AM
Study NCT ID:
NCT02546102
Status:
SUSPENDED
Last Update Posted:
2024-04-03
First Post:
2015-09-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
Sponsor:
Precision Life Sciences Group
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ICT-107-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |